VIMAB Group AB (publ) OMXSTO:VIMAB:
AERIX REPLACES GRIMALDI AS ACQUIRER OF VIMAB AB
PURCHASE PRICE SEK 140 MILLION
Aerix Replaces Grimaldi As Acquirer Of Vimab AB
Earlier from VIMAB
- Vimab Q3 Net Sales SEK 93 Million
- VIMAB: Revenue fell 17.5% in Q2, but major post-period deals are set to boost H2 results
- VIMAB: Revenue and profit declined, but large battery orders and new financing support future prospects
- VIMAB: Major loss in 2024, but large battery orders and divestment set stage for 2025 turnaround
- VIMAB: Q3 loss amid revenue drop, but record battery order and strategic shift signal future growth
Later from VIMAB
- Vimab Group Resolves On Rights Issue Of SEK 127.4 Mln
- Sagri Development, Aerix Industri Cancel Deal On Acquisition Of Vimab Ab
- Vimab Group Announces Preliminary Outcome Of Rights Issue
- Vimab Group Q4 Net Sales SEK 86.6 Mln
- Vimab Group Divests Unit Steambox AB
Follow VIMAB into a list and get an email when it puts out news.
Follow VIMAB